In this resource library we share documents, presentations, forms, videos and useful links from Pinnacle and the wider sector.
Use the search box and filters to help find what you're looking for or view all COVID-19 resources
Can't find what you need? Try searching in programmes.
In October 2024, Pharmac introduced funded diabetes technology for people living with type 1 diabetes. Most people who choose to use this technology are now established on CGM, and more than 60 per cent are using insulin pumps or automated insulin delivery systems.
As more of these patients begin requesting prescriptions for pump and CGM consumables through primary care, we’ve created this guide to support you with the prescribing process.
Jo Scott-Jones and Dave Maplesden discuss empagliflozin and ketoacidosis, decision to fund fosfomycin in the community, latent autoimmune diabetes and more.
Jo Scott-Jones and Dave Maplesden discuss treatment refusal, salty navels, warts and gels, coffee and pre-diabetes, and more.
Jo Scott-Jones and Dave Maplesden discuss deprescribing, fever in children, pain management and more.
Jo Scott-Jones and Dave Maplesden discuss diverticulitis, new free resources available through Healthpathways, a financial benefits WINZ resource, and more.
A guide for clinical management of type 2 diabetes, including information from a variety of sources. The guide is intended to support nurses at all levels to develop their knowledge and clinical reasoning in diabetes care.
From 30 September 2024, the following insulins will no longer be available in Aotearoa New Zealand: Penmix30, Penmix50 and Mixtard30. NZSSD has issued recommendations for switching to alternative insulins.
A guide for clinical management of type 2 diabetes, including information from a variety of sources. The guide is intended to support nurses at all levels to develop their knowledge and clinical reasoning in diabetes care.
The Aotearoa Diabetes Collective has created a useful guide with templates for letters to support applications for CGM and empagliflozin (for those already prescribed a GLP1ra) for people living with type 2 diabetes.
If you are in a pickle with an aspect of your practice population care (immunisation, cervical screening, CVRAs), Jo Scott-Jones suggests reviewing, judging and and acting on a "set piece" response.